Table S3.
Variable | Parameter | Range
|
Source | |
---|---|---|---|---|
Low | High | |||
Event rates for clopidogrel (1-year decision tree) | ||||
Dead any cause | 0.0545 | 0.0500 | 0.0590 | 95% confidence intervals based on PLATO data |
Nonfatal MI | 0.0522 | 0.0477 | 0.0567 | |
Nonfatal stroke | 0.0080 | 0.0062 | 0.0097 | |
Hazard ratios for ticagrelor versus clopidogrel (1-year decision tree) | ||||
Dead any cause | 0.78 | 0.69 | 0.89 | 95% confidence intervals based on PLATO data |
Nonfatal MI | 0.86 | 0.76 | 0.98 | |
Nonfatal stroke | 1.09 | 0.80 | 1.49 | |
Utilities from PLATO study | ||||
No further event | 0.875 | 0.871 | 0.879 | 95% confidence intervals based on PLATO HECON substudy |
New MI | 0.812 | 0.792 | 0.832 | |
New stroke | 0.736 | 0.662 | 0.810 | |
Dead any cause | 0.249 | 0.222 | 0.276 | |
New MI (mm) | 0.812 | 0.792 | 0.832 | |
Post-MI/no event (mm) | 0.854 | 0.834 | 0.873 | |
New stroke (mm) | 0.736 | 0.662 | 0.810 | |
Post-stroke (mm) | 0.736 | 0.662 | 0.810 | |
Resource cost for the Markov model | ||||
New MI | $10,824 | $8,659 | $12,989 | Costs were varied by ±20% |
Post-MI/no event | $3,112 | $2,490 | $3,734 | |
New stroke | $20,823 | $16,658 | $24,988 | |
Post-stroke | $4,336 | $3,469 | $5,203 |
Note: All values are in Canadian dollars.
Abbreviations: MI, myocardial infarction; PLATO, Platelet Inhibition and Patient Outcomes.